Mira Pharma (MIRA)
0.75
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 10-Q MIRA PHARMACEUTICALS, For: Jun 30
August 12, 2026 4:18 PM - SEC Filing
Form 8-K MIRA PHARMACEUTICALS, For: Aug 06
August 6, 2026 8:00 AM - SEC Filing
MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
August 6, 2026 8:00 AM - Globe NewsWire
MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
August 6, 2026 8:00 AM - StreetInsider
Form 8-K MIRA PHARMACEUTICALS, For: Jul 27
July 31, 2026 5:00 PM - SEC Filing
MIRA Pharmaceuticals completes toxicology studies for two drug candidates
July 30, 2026 8:02 AM - StreetInsider
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
July 30, 2026 8:00 AM - StreetInsider
Form DEF 14A MIRA PHARMACEUTICALS, For: Jul 28
July 28, 2026 5:00 PM - SEC Filing
Mira Pharmaceuticals reports oral formulation progress for MIRA-55
July 10, 2026 8:02 AM - StreetInsider
MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain
July 10, 2026 8:01 AM - StreetInsider
Form 8-K MIRA PHARMACEUTICALS, For: Jul 10
July 10, 2026 8:00 AM - SEC Filing
Form 8-K MIRA PHARMACEUTICALS, For: Jul 06
July 6, 2026 9:00 AM - SEC Filing
MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction
July 6, 2026 9:00 AM - StreetInsider
Mira Pharmaceuticals reports new preclinical data on Mira-55
June 25, 2026 8:15 AM - StreetInsider
MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC
June 25, 2026 8:15 AM - StreetInsider
Form 8-K MIRA PHARMACEUTICALS, For: Jun 25
June 25, 2026 8:01 AM - SEC Filing
Form 8-K MIRA PHARMACEUTICALS, For: Jun 17
June 17, 2026 8:01 AM - SEC Filing
MIRA Pharmaceuticals files Phase 2a trial protocol for CIPN drug
June 17, 2026 8:00 AM - StreetInsider
MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy
June 17, 2026 8:00 AM - StreetInsider
Form 4 MIRA PHARMACEUTICALS, For: Jun 12 Filed by: Shekhat Denil Nanji
June 15, 2026 5:00 PM - SEC Filing
Form 4 MIRA PHARMACEUTICALS, For: Jun 12 Filed by: Del Giudice Matthew Paul
June 15, 2026 5:00 PM - SEC Filing
Form 4 MIRA PHARMACEUTICALS, For: Jun 12 Filed by: Whalen Matthew Pratt
June 15, 2026 5:00 PM - SEC Filing
Form 4 MIRA PHARMACEUTICALS, For: Jun 12 Filed by: MacPherson Edward Clouston
June 15, 2026 5:00 PM - SEC Filing
Form 3 MIRA PHARMACEUTICALS, For: Jun 02 Filed by: Mushak Andriy
June 9, 2026 5:00 PM - SEC Filing
Form 8-K MIRA PHARMACEUTICALS, For: Jun 02
June 8, 2026 5:01 PM - SEC Filing
MIRA Pharmaceuticals secures global rights to drug candidates
June 4, 2026 8:02 AM - StreetInsider
Form 8-K MIRA PHARMACEUTICALS, For: Jun 03
June 4, 2026 8:01 AM - SEC Filing
MIRA Pharmaceuticals Secures Worldwide Exclusive Rights to MIRA-55 and SKNY-1
June 4, 2026 8:00 AM - StreetInsider
Full Article List
